Heme Metabolism‐Derived Carbon Monoxide Regulates Skeletal Muscle Function
Journal of Cachexia, Sarcopenia and Muscle · 2026-06 · 17 (3)
DOI: 10.1002/jcsm.70309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 14.05.2026. Verfasst von Rodrigo W Alves de Souza und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Muscle, Skeletal, Carbon Monoxide, Heme. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Defense, US Government, American Heart Association, NIH HHS.
Abstract (Originalsprache)
Background
Heme oxygenases, HO‐1 ( Hmox1 ) and HO‐2 ( Hmox2 ), regulate skeletal muscle homeostasis by degrading heme and generating carbon monoxide (CO), a bioactive signalling molecule. Although HO‐1 is known to influence muscle fibre composition and mitochondrial function, the role of HO‐2 in activity‐dependent neuromuscular plasticity remains poorly understood. This study aimed to define the distinct contributions of each isoform and test whether CO could restore muscle function in HO‐deficient states.
Methods
We generated Hmox1/2 double‐knockout mice ( Hmox1/2 −/− ) and compared their skeletal muscle phenotype with that of single HO‐1 or HO‐2 knockouts and wild‐type (WT) controls under sedentary and exercised conditions. We evaluated endurance capacity using treadmill running ( n = 8–12 per group), assessed fibre‐type distribution and neuromuscular junction (NMJ) morphology via immunohistochemistry and measured mitochondrial function using high‐resolution respirometry. Primary neuronal cultures were analysed using multielectrode array recordings to assess firing dynamics. Inhaled CO was administered to test its capacity to rescue muscle phenotype and performance.
Results
HO‐1 deficiency led to a significant reduction in oxidative fibres (Type I and IIa), decreased mitochondrial respiratory capacity (reduced by ~30%, p < 0.01) and diminished treadmill endurance (−40% running time vs. WT, p < 0.001). Hmox2 deficiency was associated with NMJ remodelling, increased acetylcholine receptor expression, reduced Sox2 transcription and heightened burst firing. The double deletion of HO‐1/HO‐2 produced an additive phenotype characterized by severe mitochondrial dysfunction, increased glycolytic fibre content and NMJ remodelling. We identify CO, a by‐product of HO‐1, as a crucial modulator of skeletal muscle adaptation, capable of compensating for HO deficiency. Treatment with CO in Hmox1/2 −/− mice restored fibre‐type distribution toward oxidative fibres (increased by 25%, p < 0.01), improved mitochondrial respiratory parameters and doubled endurance performance ( p < 0.001). CO also normalized mitochondrial protein expression and modulated key metabolic pathways, including nucleotide metabolism, the TCA cycle and redox balance.
Conclusions
HO‐1 and HO‐2 have distinct roles in regulating muscle phenotype and metabolic adaptation. HO‐1 modulates mitochondrial content and muscle plasticity, whereas Hmox2 regulates, in part, activity‐dependent neuromuscular plasticity and responsiveness to exercise. Exogenous CO effectively restores mitochondrial and functional deficits in HO‐deficient muscle, mimicking endurance exercise adaptations. These findings support the therapeutic potential of CO in conditions of muscle disuse, aging or disease where exercise is limited or not feasible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
- School of Physical Education and Sport, University of São Paulo, SP, Brazil.
- Department of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
ORCID-Profile: Rodrigo W Alves de Souza, Leo E Otterbein
Förderung
- Department of Defense, US Government
- American Heart Association
- NIH HHS
- NIDDK NIH HHS
- Sao Paulo Research Foundation (FAPESP), Brazil
- National Institutes of Health
- U.S. Department of Defense
Zitieren
APA
Alves de Souza, R. W., In Kim, H., Alves, P. K. N., da Paixão, A. O., Rasmussen, A., Shankar, S., Harbison, J., Voltarelli, V. A., & Otterbein, L. E. (2026). Heme Metabolism‐Derived Carbon Monoxide Regulates Skeletal Muscle Function. Journal of Cachexia, Sarcopenia and Muscle, 17(3). https://doi.org/10.1002/jcsm.70309
Vancouver
Alves de Souza RW, In Kim H, Alves PKN, da Paixão AO, Rasmussen A, Shankar S, et al. Heme Metabolism‐Derived Carbon Monoxide Regulates Skeletal Muscle Function. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(3). doi:10.1002/jcsm.70309
BibTeX
@article{AlvesdeSouza2026,
author = {Alves de Souza, Rodrigo W and In Kim, Hyo and Alves, Paula Ketilly Nascimento and da Paixão, Ailma Oliveira and Rasmussen, Ashlee and Shankar, Sidharth and Harbison, James and Voltarelli, Vanessa Azevedo and Otterbein, Leo E},
title = {Heme Metabolism‐Derived Carbon Monoxide Regulates Skeletal Muscle Function},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2026},
volume = {17},
number = {3},
doi = {10.1002/jcsm.70309}
}
EUVIMED